Perrigo Company plc (NYSE:PRGO – Get Free Report) Director Geoffrey Parker purchased 7,500 shares of the stock in a transaction dated Wednesday, November 12th. The stock was bought at an average cost of $14.18 per share, with a total value of $106,350.00. Following the transaction, the director owned 17,375 shares in the company, valued at $246,377.50. The trade was a 75.95% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Perrigo Stock Performance
Perrigo stock traded down $0.15 during mid-day trading on Friday, reaching $13.82. 1,774,782 shares of the stock traded hands, compared to its average volume of 1,705,094. The business’s 50-day moving average is $20.59 and its 200-day moving average is $24.12. Perrigo Company plc has a 12-month low of $13.46 and a 12-month high of $30.93. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.32 and a quick ratio of 1.24. The stock has a market capitalization of $1.90 billion, a PE ratio of -23.80 and a beta of 0.42.
Perrigo (NYSE:PRGO – Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.75 by $0.05. Perrigo had a positive return on equity of 9.09% and a negative net margin of 1.86%.The firm had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same period in the prior year, the business posted $0.81 EPS. Perrigo’s revenue was down 4.1% on a year-over-year basis. Perrigo has set its FY 2025 guidance at 2.700-2.80 EPS. As a group, sell-side analysts predict that Perrigo Company plc will post 2.56 EPS for the current fiscal year.
Perrigo Dividend Announcement
Analysts Set New Price Targets
A number of research analysts have recently weighed in on PRGO shares. Canaccord Genuity Group cut their price objective on Perrigo from $40.00 to $20.00 and set a “buy” rating for the company in a research report on Thursday, November 6th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 price objective (down from $32.00) on shares of Perrigo in a report on Thursday, November 6th. Weiss Ratings restated a “sell (d)” rating on shares of Perrigo in a research report on Wednesday, October 8th. Wall Street Zen downgraded Perrigo from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Finally, Jefferies Financial Group decreased their price target on Perrigo from $27.00 to $23.00 and set a “hold” rating on the stock in a report on Monday, October 27th. One equities research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Reduce” and an average target price of $22.50.
Get Our Latest Stock Analysis on Perrigo
Institutional Investors Weigh In On Perrigo
Several institutional investors have recently added to or reduced their stakes in PRGO. Geneos Wealth Management Inc. grew its position in Perrigo by 439.1% during the 1st quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock worth $27,000 after purchasing an additional 786 shares during the last quarter. Huntington National Bank increased its holdings in Perrigo by 237.8% in the 2nd quarter. Huntington National Bank now owns 1,054 shares of the company’s stock worth $28,000 after acquiring an additional 742 shares in the last quarter. MassMutual Private Wealth & Trust FSB raised its position in shares of Perrigo by 54.6% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,201 shares of the company’s stock worth $32,000 after purchasing an additional 424 shares during the last quarter. Hantz Financial Services Inc. increased its stake in Perrigo by 101.0% during the 2nd quarter. Hantz Financial Services Inc. now owns 1,234 shares of the company’s stock worth $33,000 after buying an additional 620 shares in the last quarter. Finally, Picton Mahoney Asset Management acquired a new position in shares of Perrigo during the first quarter valued at approximately $42,000. Institutional investors and hedge funds own 95.91% of the company’s stock.
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Read More
- Five stocks we like better than Perrigo
- Investing in the High PE Growth Stocks
- Here’s What We Learned From AST SpaceMobile’s Q3 Earnings Report
- Why Invest in 5G? How to Invest in 5G Stocks
- 3 Stocks Quietly Leveraging AI While Everyone Chases NVIDIA
- High Dividend REITs: Are They an Ideal Way to Diversify?
- LightPath Stock Eyes 50% Upside on Defense Demand Surge
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.
